Table 2.
Participant characteristics
| Interviewees with direct care responsibilities | 30 | |
| Type of healthcare professional | Consultant | 23 |
| Nursing | 4 | |
| Other | 3 | |
| Consultants’ specialisms | Clinical oncology | 7 |
| Medical oncology | 6 | |
| Haematology | 6 | |
| Paediatric medicine | 3 | |
| Surgery | 1 | |
| Consultants’ site/sub-specialisms* | Haematological malignancies | 5 |
| Gastro-intestinal cancers | 4 | |
| CNS/Neurological | 3 | |
| Genito-urinary cancers | 3 | |
| Breast cancer | 2 | |
| Gynaecological cancers | 2 | |
| Head, neck & thyroid cancers | 2 | |
| Sarcomas | 2 | |
| Paediatric oncology | 2 | |
| Lung cancer | 1 | |
| Melanoma | 1 | |
| MCUP | 1 | |
| If also had research development or support responsibilities | No | 25 |
| Yes | 5 | |
| Type of responsibilities | Senior role in a CTU or CRF | 3 |
| Specialist trial support** | 2 | |
| Board to which primarily affiliated | NHS Lothian | 11 |
| NHS Greater Glasgow & Clyde | 8 | |
| NHS Highland | 4 | |
| NHS Tayside | 3 | |
| NHS Grampian | 2 | |
| NHS Fife | 1 | |
| Other primary affiliation*** | 1 |
* Several consultants worked in more than one sub-specialism; therefore, these numbers do not sum to 23
** With regard to pharmaceutical or radiographic components
*** Interviewee primarily affiliated to an institution outside Scotland